{"id":6931,"date":"2016-11-21T14:57:09","date_gmt":"2016-11-21T14:57:09","guid":{"rendered":"http:\/\/fefac.cat\/empresarial\/?p=6931"},"modified":"2016-11-21T14:57:09","modified_gmt":"2016-11-21T14:57:09","slug":"el-sistema-sanitari-davant-el-repte-dassumir-el-c","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/","title":{"rendered":"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors"},"content":{"rendered":"

Els sistemes de salut es troben davant el repte de garantir l’accés d’aquests tractaments als pacients que ho necessiten. En els darrers anys, han entrat fàrmacs d’alt cost adreçats a patologies que presenten una alta prevalença en la població, com l’hepatitis C, amb dificultats per finançar-los.<\/p>\n

Les diferents comunitats autònomes estan cercant fórmules que minimitzin la incertesa que presenten aquests medicaments, tant pel que fa a la seva indicació com als resultats esperats. Davant d'aquesta necessitat, els responsables de farmàcia es van reunir el passat dimecres a la seu del Servei Català de la Salut (CatSalut) amb l’objectiu de debatre els reptes de futur que suposen per al sistema sanitari aquests tractaments d’elevat cost i alta prevalença i consensuar solucions.<\/p>\n

En el marc d’aquesta reunió, el director del CatSalut, David Elvira, va destacar la importància d’establir criteris d’incorporació de medicaments innovadors que tenen un elevat cost a la cartera de serveis públics, per tal de garantir un accés equitatiu a aquests fàrmacs i tractaments, garantint la sostenibilitat del sistema.<\/p>\n

Aquests medicaments són, sobretot, els nous anticossos monoclonals per al tractament del colesterol, els del tractament de la insuficiència cardíaca, els nous antivirals per al tractament de l’hepatitis C i les teràpies biològiques de la malaltia inflamatòria intestinal.<\/p>\n

A la jornada hi han assistit, a més de representants de Catalunya, membres de les comunitats autònomes d’Andalusia, Astúries, Balears, Cantàbria, Castella-la Manxa, Extremadura, Galicia, Madrid, País Basc i País València. <\/p>\n

Segons el gerent de Farmàcia i el Medicament de CatSalut, Antoni Gilabert, és important generar debat, per veure com es pot abordar des de tots els punts de vista la qüestió, ja sigui a través de la fixació de preus, harmonització de protocols, prescripció, dispensació i ús d’aquests medicaments.<\/p>\n","protected":false},"excerpt":{"rendered":"

Els sistemes de salut es troben davant el repte de garantir l’accés d’aquests tractaments als pacients que ho necessiten. En els darrers anys, han entrat fàrmacs d’alt cost adreçats a […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[11,12,13,14,15,294],"tags":[135,591],"class_list":["post-6931","post","type-post","status-publish","format-standard","hentry","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-politica-sanitaria","tag-catsalut","tag-medicaments-innovadors"],"yoast_head":"\nEl sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors - FEFAC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors - FEFAC\" \/>\n<meta property=\"og:description\" content=\"Els sistemes de salut es troben davant el repte de garantir l’accés d’aquests tractaments als pacients que ho necessiten. En els darrers anys, han entrat fàrmacs d’alt cost adreçats a […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-21T14:57:09+00:00\" \/>\n<meta name=\"author\" content=\"qabh859\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"qabh859\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/\"},\"author\":{\"name\":\"qabh859\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"headline\":\"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors\",\"datePublished\":\"2016-11-21T14:57:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/\"},\"wordCount\":396,\"keywords\":[\"CatSalut\",\"medicaments innovadors\"],\"articleSection\":[\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Pol\u00edtica sanit\u00e0ria\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/\",\"name\":\"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"datePublished\":\"2016-11-21T14:57:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\",\"name\":\"qabh859\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/qabh859\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors - FEFAC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/","og_locale":"ca_ES","og_type":"article","og_title":"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors - FEFAC","og_description":"Els sistemes de salut es troben davant el repte de garantir l’accés d’aquests tractaments als pacients que ho necessiten. En els darrers anys, han entrat fàrmacs d’alt cost adreçats a […]","og_url":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/","og_site_name":"FEFAC","article_published_time":"2016-11-21T14:57:09+00:00","author":"qabh859","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"qabh859","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/"},"author":{"name":"qabh859","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"headline":"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors","datePublished":"2016-11-21T14:57:09+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/"},"wordCount":396,"keywords":["CatSalut","medicaments innovadors"],"articleSection":["FEFAC","AFB","AFET","AFELL","AGFE","Pol\u00edtica sanit\u00e0ria"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/","url":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/","name":"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"datePublished":"2016-11-21T14:57:09+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/el-sistema-sanitari-davant-el-repte-dassumir-el-c\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"El sistema sanitari davant el repte d\u2019assumir el cost dels medicaments innovadors"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7","name":"qabh859","url":"https:\/\/fefac.cat\/empresarial\/author\/qabh859\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/6931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=6931"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/6931\/revisions"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=6931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=6931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=6931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}